跳至主要内容
临床试验/JPRN-UMIN000031156
JPRN-UMIN000031156招募中2 期

Phase II study of photodynamic therapy (PDT) for malignant meningioma - PDT for malignant meningioma

Kobe University Hospital0 个研究点目标入组 35 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subject is known, suspected or has history of intolerance or allergy to Talaporfin Sodium. (2) Subjects with porphyria. (3) Severe liver and renal dysfunction. (4) Subject with allergies such as a drug hypersensitivity constitution. (5) Pregnancy or Breast-Feeding: Pregnant or breast-feeding women will not be entered on this study, as risks of fetal and teratogenic adverse effects of Talaporfin Sodiumare not known.

研究者

相似试验